Pressure BioSciences, Inc. PBIO

Company Overview

Pressure BioSciences, Inc. (NASDAQ: PBIO) is a life sciences technology company focused on pressure-based platforms used in biotechnology, bioprocessing, diagnostics, and consumer products. The company develops and commercializes proprietary pressure cycling and ultra-shear technologies that are designed to improve sample preparation, biomolecule extraction, pathogen inactivation, emulsification, and formulation processes. PBIO primarily operates in the biotechnology tools and laboratory instrumentation industries, while also expanding into industrial processing applications through its ultra-shear technology platform.

The company’s primary revenue drivers historically have included sales of instrumentation systems, consumables, laboratory services, and collaborative research arrangements. Its core technologies include the Pressure Cycling Technology (PCT) platform and the Ultra Shear Technology (UST) platform. PCT is used in biological sample preparation for genomic, proteomic, and analytical workflows, while UST is being developed for applications including nanoemulsions, nutraceuticals, cosmetics, food processing, and cannabinoid formulations. Founded in 2004 and headquartered in South Easton, Massachusetts, the company evolved from a research-focused pressure technology business into a broader commercialization platform targeting both life sciences and industrial-scale processing markets.